Safety of BTDS in Subjects With Osteoarthritic (OA) Pain of Hip or Knee: A 6-Month Open-label Extension Phase

PHASE3CompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Osteoarthritis
Interventions
DRUG

Buprenorphine transdermal patch

Buprenorphine transdermal patch 5 mcg/h applied for 7-day wear

DRUG

Buprenorphine transdermal patch

Buprenorphine transdermal patch 10 mcg/h applied for 7-day wear

DRUG

Buprenorphine transdermal patch

Buprenorphine transdermal patch 20 mcg/h applied for 7-day wear

Trial Locations (42)

10021

Beth Israel/Dept. of Pain, New York

16630

Research Facility, Cresson

16635

Altoona Center for Clinical Research, Duncansville

16801

University Orthopedics & Sport Medicine Center, State College

19611

Research Facility, West Reading

23454

Hilltop Medical Center, Virginia Beach

27103

Research Facility, Winston-Salem

29406

Low Country Rheumatology, PA, Charleston

30060

Research Facility, Marietta

32114

Allergy, Asthma, Arthritis & Lung, Daytona Beach

32720

University Clinical Research Deland, DeLand

32763

Coastal Medical Research, Orange City

33324

Research Facility, Plantation

33409

Research Facility, West Palm Beach

33458

Research Facility, Jupiter

33462

Research Facility, Atlantis

42071

Primary Care Medical Center, Murray

47201

Research Facility, Columbus

47712

Research Facility, Evansville

49601

Great Lakes Family Care, Cadillac

49684

Research Facility, Traverse City

57201

Central Plains Clin-Brown Site, Watertown

75251

Research Facility, Dallas

76548

Research Facility, Harker Heights

78155

Research Facility, Seguin

78217

Research Facility, San Antonio

80031

Research Facility, Westminster

80209

Research Facility, Denver

84120

Granger Medical Clinic, West Valley City

85012

Arthrocare, Arthritis Care and Research, Phoenix

85015

Arizona Rheumatology Ctr and Phoenix Ctr for Clinical Research, Phoenix

85023

Arizona Research Center, Phoenix

85206

Vista Medical Research Inc., Mesa

85712

Research Facility, Tucson

90630

Orange County Clinical Research, Cypress

92120

San Diego Arthritis & Osteoporosis Medical Clinic, San Diego

92128

Research Facility, San Diego

93311

Advanced Pain Medicine, Bakersfield

94121

Research Facility, San Francisco

98026

Research Facility, Bellevue

98405

Internal Medicine Northwest, Tacoma

06606

Research Facility, Bridgeport

All Listed Sponsors
lead

Purdue Pharma LP

INDUSTRY

NCT01141283 - Safety of BTDS in Subjects With Osteoarthritic (OA) Pain of Hip or Knee: A 6-Month Open-label Extension Phase | Biotech Hunter | Biotech Hunter